Contact Us
Physician Portal
May 5-8 in San Diego, CA

ASCRS 2023

Interested in Joining Our Happy Hour?

Join us at Coasterra – a premier waterfront dining destination in San Diego. We are thrilled to host this exciting event where we will celebrate you for helping drive innovation in regenerative medicine in the field of Ophthalmology.

RSVP Here!

Visit our Booth #2644!

Visit booth #2644 at ASCRS 2023 to learn how BioTissue Ocular products can help support regenerative healing and provide optimal outcomes to your patients.

BioTissue has been a pioneer in the industry for over 37 years and continues to lead the way in realizing the full potential of regenerative therapies. Our technology defines the most human way to heal. We are passionate about empowering physicians to help improve patient lives and set the standards that define next-generation care.

Don’t forget to visit our table on May 5th for Cornea Day where we highlight how our products can be used for challenging cornea cases and management of severe ocular surface diseases!

Featured Posters

  • Cryopreserved Amniotic Membrane during Pterygium Excision: Health Economic Opportunity Analysis​ by Neel Desai, MD​ – On Demand throughout conference
  • Outcomes of the Tissuetuck Surgical Technique for Recurrent Pterygium​ by Neel Desai, MD – Saturday, May 6, 1:30 pm – 3:00 pm, SDCC, Room 1B, Paper #89982
  • Retrospective Review of Conjunctivochalasis Surgery with Cryopreserved Amniotic Membrane​ by Jose Quiceno, MD – On Demand throughout conference
  • Retrospective Review of Pterygium Surgery with Cryopreserved Amniotic Membrane by Jose Quiceno, MD – Saturday, May 6, 1:30 pm – 3:00 pm, Paper #90555​
  • Ocular Surface Optimization with Cryopreserved Amniotic Membrane Prior to Cataract Surgery by Jeff Wongs, MD​ – Sunday, May 7, 8:00 am – 9:30 am, Paper #89438

Ever had a Selfie-Cappuccino?

To show our appreciation, we are offering EuroBar coffee at our booth!

Saturday: 8am – 12pm​
Sunday: 8am – 12pm​
Monday: 8am – 12pm​

Join Us for an Innovator Celebration Happy Hour!

We’re back for our annual ASCRS Happy Hour! Join us at Coasterra – a premier waterfront dining destination in San Diego. We are thrilled to host this exciting event where we will celebrate you for helping drive innovation in regenerative medicine in the field of Ophthalmology.

RSVP Here!
Ocular Healing

BioTissues Family of Amniotic Membrane Products

Prokera®
01

Early intervention is critical in eye care. Prokera corneal bandages are designed for treating damaged corneas by creating an environment for regenerative healing. Prokera helps expedite and empower the eye’s healing abilities for better patient outcomes.

AmnioGraft®
02

AmnioGraft, a cryopreserved amniotic membrane graft, supports accelerated post-op recovery and ensures superior patient outcomes when used in ocular surface reconstructive procedures.1,6-7,9

AmnioGuard®
03

AmnioGuard is an ultra-thick, cryopreserved amniotic membrane graft that suppresses inflammation, promotes healing, and provides durable tensile strength to avoid surgical challenges associated with reconstructive procedures.1-4

Downloadable Resources

  • To access downloadable resources, kindly fill out the form below.
  • By clicking the button below, I agree to receive marketing communications from BioTissue. I am aware that I can unsubscribe at any time.
  • This field is for validation purposes and should be left unchanged.
References
Sheha H, Tello C, Al-Aswad L, Sayed M, Lee R. Outcomes of the Shunt Tube Exposure Prevention Study (STEPS), a randomized clinical trial. Opthalmol Glaucoma. [Online] August 16, 2019.
Finger PT, Jain P, Mukkamala SK. Super-thick amniotic membrane for ocular surface reconstruction. Am J Opthalmol. 2019;198:45-53.
Slentz, D. and Nelson, C. (2019). Novel Use of Cryopreserved Ultra-thick Human Amniotic Membrane for Management of Anophthalmic Socket Contracture. Ophthalmic Plastic and Reconstructive Surgery, 35(2), pp.193-196.
Johnson, Amy, et al. “Understanding the impact of preservation methods on the integrity and functionality of placental allografts.” Annals of plastic surgery 79.2 (2017): 203-213.
Solomon A, Pires RTF and Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001; 108: 449-60.
Cooke M, Tan EK, Mandrycky C, He H, O'Connell J and Tseng SC. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissuJWoundCare. 2014; 23: 465-76.
Tan EK, Cooke M, Mandrycky C, et al. Structural and Biological Comparison of Cryopreserved and Fresh Amniotic Membrane Tissues. Journal of Biomaterials and Tissue Engineering. 2014; 4: 379-88.
Tighe S, Mead O, Lee A and Tseng S. Basic Science Review of Birth Tissue Uses in Ophthalmology. Taiwan Journal of Ophthalmology. 2020;
Kheirkhah A, Casas V, Esquenazi S, et al. New surgical approach for superior conjunctivochalasis. Cornea. 2007;26(6):685-691.
Tseng S, Espana E, Kawakita T, et al. How does amniotic membrane work? The Ocular Surface. 2004; 2(3):177-187.
13. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved human amniotic membrane. Cornea. 2001; 20(6):619-621.
Contact Us
Physician Portal